Lily Wang

Founder

Bioipolaris

Personal Profile

With over 16 years of experience in biopharmaceutical patent consulting and management, she has worked at multinational pharmaceutical companies, innovative drug R&D firms, and a Hong Kong-listed pharmaceutical enterprise, specializing in patent analysis, patent applications, patent portfolio manage ment, and patent team leadership. She has extensive experience in the full life-cycle management of newdrug patents, global intellectual property strategy planning, as well as domestic and international phar maceutical licensing transactions and technology transfers with universities and research institutions. She has previously been employed at Novartis, WuXi Biologics, Ascentage Pharma, Allist Pharmaceuticals, and the Technology Transfer Center of the Shanghai Institutes for Biological Sciences, Chinese Academy of Sci
ences.

• In April 2023, she founded BioIPolaris, providing patent strategy consulting services to drug and device R&D companies, healthcare funds, and incubation platforms, and building a comprehensive IP service and global technology transfer support platform.

• From 2022 to 2023, she served as VP of Operations and General Counsel at a startup focused on novel drug R&D, overseeing operations, legal affairs, IP, and financing support.

• From 2018 to 2022, she served as Senior Director and Head of the Intellectual Property Department at Ascentage Pharma, responsible for global IP management and life-cycle management of the IP portfolio, providing intellectual property guidance and support in process development and manufacturing, pre-clinical and clinical research, and business development.

• From 2017 to 2018, she worked as IP Counsel and Associate Director at WuXi Biologics, where she was responsible for patent portfolio management, patent drafting and applications, patent search and analysis, as well as patent transfers and licensing.

• From 2012 to 2017, she worked at Novartis for over five years, focusing on competitive intelligence, patentability studies, and due diligence analysis.

  • About Us

    IP ForeFront is an omni-media information platform operated by Shanghai YIP Events Co., Ltd. Specialized in intellectual property, IP ForeFront features in-depth, high-quality and original IP policy insights, case analysis, and international & domestic updates. IP ForeFront also provides IP training, industry summit organization and media services.

© Copyright 2019-2025 Shanghai YIP Events Co., Ltd. All rights reserved. Designed by：Bangnie

沪ICP备19003185号-1